Potential benefits of eicosapentaenoic acid on atherosclerotic plaques.Nelson JR, Wani O, May HT, Budoff MVascul Pharmacol. 2017 Apr;91:1-9. doi: 10.1016/j.vph.2017.02.004. Epub 2017 Mar 2. Eicosapen ...

Read the full Tiiip

(Send your comment)

Potential benefits of eicosapentaenoic acid on atherosclerotic plaques.
Nelson JR, Wani O, May HT, Budoff M
Vascul Pharmacol. 2017 Apr;91:1-9. doi: 10.1016/j.vph.2017.02.004. Epub 2017 Mar 2.

Eicosapentaenoic Acid Modulates Trichomonas vaginalis Activity.
Korosh T, Jordan KD, Wu JS, Yarlett N, Upmacis RK
J Eukaryot Microbiol. 2016 Mar-Apr;63(2):153-61. doi: 10.1111/jeu.12263. Epub 2015 Sep 23.

Research Progress on the Risk Factors and Outcomes of Human Carotid Atherosclerotic Plaques.
Xiong XD, Xiong WD, Xiong SS, Chen GH
Chin Med J (Engl). 2017 Mar 20;130(6):722-729. doi: 10.4103/0366-6999.201598.

The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.
Nelson JR, Raskin S.
Postgrad Med. 2019 May 7:1-10.

Eicosapentaenoic acid suppresses angiogenesis via reducing secretion of IL‑6 and VEGF from colon cancer‑associated fibroblasts.
Ando N, Hara M, Shiga K, Yanagita T, Takasu K, Nakai N, Maeda Y, Hirokawa T, Takahashi H, Ishiguro H, Matsuo Y, Takiguchi S.
Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7141.

Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia.
Doggrell SA.
Expert Opin Pharmacother. 2019 Apr 30:1-5. doi: 10.1080/14656566.2019.1609942.

Sign up to vote this object, vote his reviews and to contribute to Tiiips.Evaluate